EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Development of a core outcome set for treatment studies for provoked vestibulodynia

Nina Bohm-Starke, Caroline Pukall, Marie Österberg, Maria Ahlberg, Ann Kristine Jonsson, Sofia Tranæus, Susanna Kempe, Christel Hellberg

The Journal of Sexual Medicine · 2024

DOI: 10.1093/jsxmed/qdae035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Sexual Medicine, 2024. Verfasst von Nina Bohm-Starke und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Obstetrics and Gynecology, Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, 171 77 Stockholm, Sweden. Hauptthemen laut MEDLINE: Vulvodynia, Delphi Technique. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Swedish Agency for Health Technology Assessment, Assessment of Social Services.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There is an inconsistency in treatment outcomes used in clinical trials for provoked vestibulodynia (PVD), which makes it impossible to compare the effects of different interventions.

Aim

In this study, we completed the first step in creating a core outcome set (COS), defining what outcomes should be measured in clinical trials for PVD.

Methods

Identification of outcomes used in studies was done by extracting data from clinical trials in a recently published systematic review and via review of clinical trials for PVD registered on ClinicalTrials.gov. The COS process consisted of 2 rounds of Delphi surveys and a consensus meeting, during which the final COS was decided through a modified nominal group technique. Outcomes Consensus on what outcomes to include in a COS for PVD.

Results

Forty scientific articles and 92 study protocols were reviewed for outcomes. Of those, 36 articles and 25 protocols were eligible, resulting in 402 outcomes, which were then categorized into 63 unique outcomes. Participants consisted of patients, relatives/partners of patients, health care professionals, and researchers. Out of 463 who registered for participation, 319 and 213 responded to the first and second surveys, respectively. The consensus meeting consisted of 18 members and resulted in 6 outcomes for the COS to be measured in all treatment trials regardless of intervention: insertional pain (nonsexual), insertional pain (sexual), provoked vulvar pain by pressure/contact, pain-related interference on one’s life, pain interference on sexual life, and sexual function. Clinical Implications Critical outcomes to be measured in clinical trials will allow for accurate comparison of outcomes across treatment interventions and provide solid treatment recommendations. Strengths and Limitations The major strengths of the study are the adherence to methodological recommendations and the intentional focus on aspects of diversity of participating stakeholders (eg, status such as patients with lived experience and researchers, inclusiveness with respect to sexual identity), the latter of which will allow for broader application and relevance of the COS. Among the limitations of the study are the low rate of participants outside North America and Europe and the lower response rate (about 50%) for the second Delphi survey.

Conclusion

In this international project, patients, health care professionals, and researchers have decided what critical outcomes are to be used in future clinical trials for PVD. Before the COS can be fully implemented, there is also a need to decide on how and preferably when the outcomes should be measured.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VulvodyniaDelphi TechniqueHumansFemaleOutcome Assessment, Health CareConsensusTreatment OutcomeClinical Trials as TopicAdultResearch Design

Stichwörter der Autor:innen

clinical trialscore outcome setprovoked vestibulodyniatreatment outcomevulvodynia

Autor:innen und Institutionen

  • Division of Obstetrics and Gynecology, Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, 171 77 Stockholm, Sweden.
  • Department of Psychology, Queen's University, Kingston, ON K7L 3N6, Canada.
  • Swedish Agency for Health Technology Assessment and Assessment of Social Services, Stockholm, 102 33, Sweden.
  • Health Technology Assessment-Odontology, Faculty of Odontology, Malmö University, 214 21 Malmö, Sweden.

Förderung

  • Swedish Agency for Health Technology Assessment
  • Assessment of Social Services

Zitieren

APA

Bohm-Starke, N., Pukall, C., Österberg, M., Ahlberg, M., Jonsson, A. K., Tranæus, S., Kempe, S., & Hellberg, C. (2024). Development of a core outcome set for treatment studies for provoked vestibulodynia. The Journal of Sexual Medicine. https://doi.org/10.1093/jsxmed/qdae035

Vancouver

Bohm-Starke N, Pukall C, Österberg M, Ahlberg M, Jonsson AK, Tranæus S, et al. Development of a core outcome set for treatment studies for provoked vestibulodynia. The Journal of Sexual Medicine. 2024. doi:10.1093/jsxmed/qdae035

BibTeX
@article{BohmStarke2024,
  author = {Bohm-Starke, Nina and Pukall, Caroline and Österberg, Marie and Ahlberg, Maria and Jonsson, Ann Kristine and Tranæus, Sofia and Kempe, Susanna and Hellberg, Christel},
  title = {Development of a core outcome set for treatment studies for provoked vestibulodynia},
  journal = {The Journal of Sexual Medicine},
  year = {2024},
  doi = {10.1093/jsxmed/qdae035}
}
Kostenlos starten →